Human group IIA secretory phospholipase A2 potentiates Ca2+ influx through L-type voltage-sensitive Ca2+ channels in cultured rat cortical neurons. 2003

Tatsurou Yagami, and Keiichi Ueda, and Kenji Asakura, and Hitoshi Nakazato, and Satoshi Hata, and Takayuki Kuroda, and Toshiyuki Sakaeda, and Gaku Sakaguchi, and Naohiro Itoh, and Yutaka Hashimoto, and Yozo Hori
Discovery Research Laboratories, Shionogi and Co. Ltd, Osaka, Japan. tatsurou.yagami@shionogi.co.jp

Mammalian group IIA secretory phospholipase A2 (sPLA2-IIA) generates prostaglandin D2 (PGD2) and triggers apoptosis in cortical neurons. However, mechanisms of PGD2 generation and apoptosis have not yet been established. Therefore, we examined how second messengers are involved in the sPLA2-IIA-induced neuronal apoptosis in primary cultures of rat cortical neurons. sPLA2-IIA potentiated a marked influx of Ca2+ into neurons before apoptosis. A calcium chelator and a blocker of the L-type voltage-sensitive Ca2+ channel (L-VSCC) prevented neurons from sPLA2-IIA-induced neuronal cell death in a concentration-dependent manner. Furthermore, the L-VSCC blocker ameliorated sPLA2-IIA-induced morphologic alterations and apoptotic features such as condensed chromatin and fragmented DNA. Other blockers of VSCCs such as N type and P/Q types did not affect the neurotoxicity of sPLA2-IIA. Blockers of L-VSCC significantly suppressed sPLA2-IIA-enhanced Ca2+ influx into neurons. Moreover, reactive oxygen species (ROS) were generated prior to apoptosis. Radical scavengers reduced not only ROS generation, but also the sPLA2-IIA-induced Ca2+ influx and apoptosis. In conclusion, we demonstrated that sPLA2-IIA potentiates the influx of Ca2+ into neurons via L-VSCC. Furthermore, the present study suggested that eicosanoids and ROS generated during arachidonic acid oxidative metabolism are involved in sPLA2-IIA-induced apoptosis in cooperation with Ca2+.

UI MeSH Term Description Entries
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D010741 Phospholipases A Phospholipases that hydrolyze one of the acyl groups of phosphoglycerides or glycerophosphatidates.
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002614 Chelating Agents Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. Chelating Agent,Chelator,Complexons,Metal Antagonists,Chelators,Metal Chelating Agents,Agent, Chelating,Agents, Chelating,Agents, Metal Chelating,Antagonists, Metal,Chelating Agents, Metal
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Tatsurou Yagami, and Keiichi Ueda, and Kenji Asakura, and Hitoshi Nakazato, and Satoshi Hata, and Takayuki Kuroda, and Toshiyuki Sakaeda, and Gaku Sakaguchi, and Naohiro Itoh, and Yutaka Hashimoto, and Yozo Hori
December 2006, Neuroreport,
Tatsurou Yagami, and Keiichi Ueda, and Kenji Asakura, and Hitoshi Nakazato, and Satoshi Hata, and Takayuki Kuroda, and Toshiyuki Sakaeda, and Gaku Sakaguchi, and Naohiro Itoh, and Yutaka Hashimoto, and Yozo Hori
August 2001, Brain research. Molecular brain research,
Tatsurou Yagami, and Keiichi Ueda, and Kenji Asakura, and Hitoshi Nakazato, and Satoshi Hata, and Takayuki Kuroda, and Toshiyuki Sakaeda, and Gaku Sakaguchi, and Naohiro Itoh, and Yutaka Hashimoto, and Yozo Hori
March 2010, Journal of neurochemistry,
Tatsurou Yagami, and Keiichi Ueda, and Kenji Asakura, and Hitoshi Nakazato, and Satoshi Hata, and Takayuki Kuroda, and Toshiyuki Sakaeda, and Gaku Sakaguchi, and Naohiro Itoh, and Yutaka Hashimoto, and Yozo Hori
January 2005, Current medicinal chemistry,
Tatsurou Yagami, and Keiichi Ueda, and Kenji Asakura, and Hitoshi Nakazato, and Satoshi Hata, and Takayuki Kuroda, and Toshiyuki Sakaeda, and Gaku Sakaguchi, and Naohiro Itoh, and Yutaka Hashimoto, and Yozo Hori
January 2003, Neuroscience,
Tatsurou Yagami, and Keiichi Ueda, and Kenji Asakura, and Hitoshi Nakazato, and Satoshi Hata, and Takayuki Kuroda, and Toshiyuki Sakaeda, and Gaku Sakaguchi, and Naohiro Itoh, and Yutaka Hashimoto, and Yozo Hori
January 1996, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics,
Tatsurou Yagami, and Keiichi Ueda, and Kenji Asakura, and Hitoshi Nakazato, and Satoshi Hata, and Takayuki Kuroda, and Toshiyuki Sakaeda, and Gaku Sakaguchi, and Naohiro Itoh, and Yutaka Hashimoto, and Yozo Hori
November 2000, Naunyn-Schmiedeberg's archives of pharmacology,
Tatsurou Yagami, and Keiichi Ueda, and Kenji Asakura, and Hitoshi Nakazato, and Satoshi Hata, and Takayuki Kuroda, and Toshiyuki Sakaeda, and Gaku Sakaguchi, and Naohiro Itoh, and Yutaka Hashimoto, and Yozo Hori
May 2012, Neurochemistry international,
Tatsurou Yagami, and Keiichi Ueda, and Kenji Asakura, and Hitoshi Nakazato, and Satoshi Hata, and Takayuki Kuroda, and Toshiyuki Sakaeda, and Gaku Sakaguchi, and Naohiro Itoh, and Yutaka Hashimoto, and Yozo Hori
January 2013, Chemistry and physics of lipids,
Tatsurou Yagami, and Keiichi Ueda, and Kenji Asakura, and Hitoshi Nakazato, and Satoshi Hata, and Takayuki Kuroda, and Toshiyuki Sakaeda, and Gaku Sakaguchi, and Naohiro Itoh, and Yutaka Hashimoto, and Yozo Hori
November 1997, Biochemistry,
Copied contents to your clipboard!